Mentions
Extended reach
Total likes
Video views
AI synopsis
The collective discussions show high interest and engagement, with posts praising the comprehensive figures, diagnostic methods, and implications for clinical practice, such as references to specific imaging techniques and genetic considerations, demonstrating a strong impact on the audience's understanding and approach to cardiac amyloidosis.
Most discussions express support and validation for the scientific statement, emphasizing the importance of early diagnosis and new treatment approaches.
The discussions consistently highlight curiosity and enthusiasm about advancements and diagnostic tools related to cardiac amyloidosis.
Many posts include detailed references to figures, diagnostic algorithms, and clinical features, indicating deep engagement with the content.
The discussions reflect recognition of the article's significant influence on clinical practices and ongoing research in cardiology.
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
Helpful and terrific figure by @MKIttlesonMD et al when you suspect cardiac #amyloidosis in your patient! The V122I mutation is commonly found in African-Americans. https://t.co/Lk7Ws9ROhV https://t.co/WEFEFrqjAv
Cardiac Amyloidosis in @CircAHA. Great information. ➡️Clinical clues from routine evaluation should prompt additional diagnostic work up ➡️Algorithm starting with monocl light chain quantification ➡️New treatments at sight.
¿Cuándo sospechar #amiloidosis? Circulation. 2020;141:00–00. DOI: 10.1161/CIR.0000000000000792 https://t.co/LFSsHPyMKG
AHA Scientific Statement for the diagnosis and management of cardiac amiloidosis @SantasEnrique @secardiologia @ValleAlfonso @yulnunezvill @dr_pavia at https://t.co/aGjPAAX0vI https://t.co/Z5euIyId5k
AHA Scientific Statement: Cardiac Amyloidosis: Evolving Diagnosis and Management https://t.co/fLrPQPVJeF @AHAScience #AHAJournals
This video covers ventricular arrhythmias associated with miscellaneous diseases, including LV noncompaction, restrictive cardiomyopathies like amyloidosis, neuromuscular disorders, inflammatory heart diseases, and…
RT @dr_ezquerra: ¿Cuándo sospechar #amiloidosis? Circulation. 2020;141:00–00. DOI: 10.1161/CIR.0000000000000792 https://t.co/LFSsHPyMKG
@Fynnderella1 Is there any chance that some of these cases of Myocarditis are misdiagnosed Cardiac Amyloidosis. https://t.co/Rp1Z9FAqx7
RT @PennCVWomen: Thrilled to welcome THE @MKIttlesonMD to @PennCardiology Grand Rounds this morning for what is sure to be a blockbuster ta…
RT @PennCVWomen: Thrilled to welcome THE @MKIttlesonMD to @PennCardiology Grand Rounds this morning for what is sure to be a blockbuster ta…
RT @PennCVWomen: Thrilled to welcome THE @MKIttlesonMD to @PennCardiology Grand Rounds this morning for what is sure to be a blockbuster ta…
Thrilled to welcome THE @MKIttlesonMD to @PennCardiology Grand Rounds this morning for what is sure to be a blockbuster talk on cardiac amyloidosis!
RT @Gurleen_Kaur96: So much fun to learn from @MKIttlesonMD on @CPSolvers! This AHA scientific statement on Cardiac Amyloidosis is a very…
RT @Gurleen_Kaur96: So much fun to learn from @MKIttlesonMD on @CPSolvers! This AHA scientific statement on Cardiac Amyloidosis is a very…
RT @Gurleen_Kaur96: So much fun to learn from @MKIttlesonMD on @CPSolvers! This AHA scientific statement on Cardiac Amyloidosis is a very…
RT @Gurleen_Kaur96: So much fun to learn from @MKIttlesonMD on @CPSolvers! This AHA scientific statement on Cardiac Amyloidosis is a very…
RT @Gurleen_Kaur96: So much fun to learn from @MKIttlesonMD on @CPSolvers! This AHA scientific statement on Cardiac Amyloidosis is a very…
RT @Gurleen_Kaur96: So much fun to learn from @MKIttlesonMD on @CPSolvers! This AHA scientific statement on Cardiac Amyloidosis is a very…
RT @janieyaya: https://t.co/qzoHqfhxYb
RT @KalinoskiDubose: Helpful and terrific figure by @MKIttlesonMD et al when you suspect cardiac #amyloidosis in your patient! The V122I mu…
RT @KalinoskiDubose: Helpful and terrific figure by @MKIttlesonMD et al when you suspect cardiac #amyloidosis in your patient! The V122I mu…
RT @KalinoskiDubose: Helpful and terrific figure by @MKIttlesonMD et al when you suspect cardiac #amyloidosis in your patient! The V122I mu…
RT @KalinoskiDubose: Helpful and terrific figure by @MKIttlesonMD et al when you suspect cardiac #amyloidosis in your patient! The V122I mu…
RT @KalinoskiDubose: Helpful and terrific figure by @MKIttlesonMD et al when you suspect cardiac #amyloidosis in your patient! The V122I mu…
RT @KalinoskiDubose: Helpful and terrific figure by @MKIttlesonMD et al when you suspect cardiac #amyloidosis in your patient! The V122I mu…
RT @KalinoskiDubose: Helpful and terrific figure by @MKIttlesonMD et al when you suspect cardiac #amyloidosis in your patient! The V122I mu…
RT @KalinoskiDubose: Helpful and terrific figure by @MKIttlesonMD et al when you suspect cardiac #amyloidosis in your patient! The V122I mu…
RT @KalinoskiDubose: Helpful and terrific figure by @MKIttlesonMD et al when you suspect cardiac #amyloidosis in your patient! The V122I mu…
RT @KalinoskiDubose: Helpful and terrific figure by @MKIttlesonMD et al when you suspect cardiac #amyloidosis in your patient! The V122I mu…
RT @KalinoskiDubose: Helpful and terrific figure by @MKIttlesonMD et al when you suspect cardiac #amyloidosis in your patient! The V122I mu…
Helpful and terrific figure by @MKIttlesonMD et al when you suspect cardiac #amyloidosis in your patient! The V122I mutation is commonly found in African-Americans. https://t.co/Lk7Ws9ROhV https://t.co/WEFEFrqjAv
RT @janieyaya: https://t.co/qzoHqfhxYb
RT @janieyaya: https://t.co/qzoHqfhxYb
https://t.co/qzoHqfhxYb
@Gontxi7 @Felipediezhoyo @JovenesSec @marestrepoc “Note that age alone is not a valid discriminator of ATTRwt versus ATTRv disease” @MKIttlesonMD https://t.co/BDV2H3st30 But, which is the odds of ATTRv in an88yo male?? Does the pretest probability be so low at some age point that genetic testing can be avoided in some groups?
@bmorecardiology @TalaAltalibMD @ASE360 @VLSorrellImages @SusanJosephMD @UM_Cardiology @AnnGageMD @gcfmd Your question is a bit general because of the different subtypes of cardiac amyloidosis. Take a look at Figure 1 of the AHA Scientific Statement for the diagnosis of cardiac amyloidosis from @MKIttlesonMD @frederickruberg et al https://t.co/jQkoyy37oR
RT @SeguraCardio:
RT @MKIttlesonMD: @AlexAndersonMD Transthyretin amyloidosis. Check technetium pyrophosphate scan, serum/urine IFE, serum free light chains.…
@AlexAndersonMD Transthyretin amyloidosis. Check technetium pyrophosphate scan, serum/urine IFE, serum free light chains. https://t.co/2SYrq3z0Ok
@LBEBEN This paper is useful for that particular question, specifically amyloid: https://t.co/V7k7dPeoB9
RT @EduardoPerna1: Great review about Cardiac Amyloidosis from @CircAHA. Keep in mind the diagnostic algorithm for ATTR @comiteic @Comunida…
RT @EduardoPerna1: Great review about Cardiac Amyloidosis from @CircAHA. Keep in mind the diagnostic algorithm for ATTR @comiteic @Comunida…
RT @EduardoPerna1: Great review about Cardiac Amyloidosis from @CircAHA. Keep in mind the diagnostic algorithm for ATTR @comiteic @Comunida…
Great review about Cardiac Amyloidosis from @CircAHA. Keep in mind the diagnostic algorithm for ATTR @comiteic @ComunidadFAC @RodrigoZoniOK @SoCaCorr @pcornicelli https://t.co/0N4ICEI2UK https://t.co/KUKlFNvPWa
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association | Circulation https://t.co/xry6iXiyp4
Found a #cherryontop
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association | Circulation https://t.co/uBONMmthpo
New2Trip: Cardiac Amyloidosis: Evolving Diagnosis & Management: Scientific Statement From American Heart Association https://t.co/nDDVRPxLqy
@cardiohiba_resi @bochusi Scientific statement, Circulation 2020
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association | Circulation https://t.co/3F7z2wYYLw
New2Trip: Cardiac Amyloidosis: Evolving Diagnosis & Management: Scientific Statement From American Heart Association https://t.co/cxP9FisDBo
New2Trip: Cardiac Amyloidosis: Evolving Diagnosis & Management: Scientific Statement From American Heart Association https://t.co/nDDVRPxLqy
New2Trip: Cardiac Amyloidosis: Evolving Diagnosis & Management: Scientific Statement From American Heart Association https://t.co/nDDVRPxLqy
RT @SISIACOficial: Amiloidosis Cardiaca: Diagnóstico y manejo / Cardiac Amyloidosis: Diagnosis and management Circulation: https://t.co/wE…
RT @SISIACOficial: Amiloidosis Cardiaca: Diagnóstico y manejo / Cardiac Amyloidosis: Diagnosis and management Circulation: https://t.co/wE…
RT @SISIACOficial: Amiloidosis Cardiaca: Diagnóstico y manejo / Cardiac Amyloidosis: Diagnosis and management Circulation: https://t.co/wE…
Amiloidosis Cardiaca: Diagnóstico y manejo / Cardiac Amyloidosis: Diagnosis and management Circulation: https://t.co/wEyfzTwCHv @chemaimagencv @filikinetico @GARCIAEDINSON95 @onco_cardiology @iamritu @purviparwani @SIAC_cardio @grareyes @mswami001 @DavidWienerMD @wikimagen https://t.co/VehwTmxmdH
RT @tripdatabase: New2Trip: Cardiac Amyloidosis: Evolving Diagnosis & Management: Scientific Statement From American Heart Association http…
RT @jpcostabel: Cardiac Amyloidosis in @CircAHA. Great information. ➡️Clinical clues from routine evaluation should prompt additional diagn…
RT @jpcostabel: Cardiac Amyloidosis in @CircAHA. Great information. ➡️Clinical clues from routine evaluation should prompt additional diagn…
New2Trip: Cardiac Amyloidosis: Evolving Diagnosis & Management: Scientific Statement From American Heart Association https://t.co/nDDVRPxLqy
RT @jpcostabel: Cardiac Amyloidosis in @CircAHA. Great information. ➡️Clinical clues from routine evaluation should prompt additional diagn…
RT @jpcostabel: Cardiac Amyloidosis in @CircAHA. Great information. ➡️Clinical clues from routine evaluation should prompt additional diagn…
RT @jpcostabel: Cardiac Amyloidosis in @CircAHA. Great information. ➡️Clinical clues from routine evaluation should prompt additional diagn…
RT @jpcostabel: Cardiac Amyloidosis in @CircAHA. Great information. ➡️Clinical clues from routine evaluation should prompt additional diagn…
RT @jpcostabel: Cardiac Amyloidosis in @CircAHA. Great information. ➡️Clinical clues from routine evaluation should prompt additional diagn…
Cardiac Amyloidosis in @CircAHA. Great information. ➡️Clinical clues from routine evaluation should prompt additional diagnostic work up ➡️Algorithm starting with monocl light chain quantification ➡️New treatments at sight.
RT @rdelaespriella: AHA Scientific Statement for the diagnosis and management of cardiac amiloidosis @SantasEnrique @secardiologia @ValleAl…
RT @rdelaespriella: AHA Scientific Statement for the diagnosis and management of cardiac amiloidosis @SantasEnrique @secardiologia @ValleAl…
RT @rdelaespriella: AHA Scientific Statement for the diagnosis and management of cardiac amiloidosis @SantasEnrique @secardiologia @ValleAl…
RT @rdelaespriella: AHA Scientific Statement for the diagnosis and management of cardiac amiloidosis @SantasEnrique @secardiologia @ValleAl…
RT @rdelaespriella: AHA Scientific Statement for the diagnosis and management of cardiac amiloidosis @SantasEnrique @secardiologia @ValleAl…
RT @rdelaespriella: AHA Scientific Statement for the diagnosis and management of cardiac amiloidosis @SantasEnrique @secardiologia @ValleAl…
RT @rdelaespriella: AHA Scientific Statement for the diagnosis and management of cardiac amiloidosis @SantasEnrique @secardiologia @ValleAl…
RT @rdelaespriella: AHA Scientific Statement for the diagnosis and management of cardiac amiloidosis @SantasEnrique @secardiologia @ValleAl…
RT @rdelaespriella: AHA Scientific Statement for the diagnosis and management of cardiac amiloidosis @SantasEnrique @secardiologia @ValleAl…
RT @rdelaespriella: AHA Scientific Statement for the diagnosis and management of cardiac amiloidosis @SantasEnrique @secardiologia @ValleAl…
RT @rdelaespriella: AHA Scientific Statement for the diagnosis and management of cardiac amiloidosis @SantasEnrique @secardiologia @ValleAl…
RT @rdelaespriella: AHA Scientific Statement for the diagnosis and management of cardiac amiloidosis @SantasEnrique @secardiologia @ValleAl…
RT @rdelaespriella: AHA Scientific Statement for the diagnosis and management of cardiac amiloidosis @SantasEnrique @secardiologia @ValleAl…
RT @rdelaespriella: AHA Scientific Statement for the diagnosis and management of cardiac amiloidosis @SantasEnrique @secardiologia @ValleAl…
RT @rdelaespriella: AHA Scientific Statement for the diagnosis and management of cardiac amiloidosis @SantasEnrique @secardiologia @ValleAl…
AHA Scientific Statement for the diagnosis and management of cardiac amiloidosis @SantasEnrique @secardiologia @ValleAlfonso @yulnunezvill @dr_pavia at https://t.co/aGjPAAX0vI https://t.co/Z5euIyId5k
@MKIttlesonMD Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association | Circulation https://t.co/tlvFF1Tzlt
New2Trip: Cardiac Amyloidosis: Evolving Diagnosis & Management: Scientific Statement From American Heart Association https://t.co/nDDVRPxLqy
New2Trip: Cardiac Amyloidosis: Evolving Diagnosis & Management: Scientific Statement From American Heart Association https://t.co/nDDVRPxLqy
New2Trip: Cardiac Amyloidosis: Evolving Diagnosis & Management: Scientific Statement From American Heart Association https://t.co/cxP9FisDBo
RT @dr_ezquerra: ¿Cuándo sospechar #amiloidosis? Circulation. 2020;141:00–00. DOI: 10.1161/CIR.0000000000000792 https://t.co/LFSsHPyMKG
RT @dr_ezquerra: ¿Cuándo sospechar #amiloidosis? Circulation. 2020;141:00–00. DOI: 10.1161/CIR.0000000000000792 https://t.co/LFSsHPyMKG
RT @dr_ezquerra: ¿Cuándo sospechar #amiloidosis? Circulation. 2020;141:00–00. DOI: 10.1161/CIR.0000000000000792 https://t.co/LFSsHPyMKG
RT @dr_ezquerra: ¿Cuándo sospechar #amiloidosis? Circulation. 2020;141:00–00. DOI: 10.1161/CIR.0000000000000792 https://t.co/LFSsHPyMKG
RT @dr_ezquerra: ¿Cuándo sospechar #amiloidosis? Circulation. 2020;141:00–00. DOI: 10.1161/CIR.0000000000000792 https://t.co/LFSsHPyMKG
¿Cuándo sospechar #amiloidosis? Circulation. 2020;141:00–00. DOI: 10.1161/CIR.0000000000000792 https://t.co/LFSsHPyMKG
RT @Ed_Alania: Cardiac Amyloidosis #cardiotwitter
RT @Ed_Alania: Cardiac Amyloidosis #cardiotwitter
RT @Ed_Alania: Cardiac Amyloidosis #cardiotwitter
RT @Ed_Alania: Cardiac Amyloidosis #cardiotwitter
RT @jsenior64: Cardiomiopatía amiloide por transtiretina. Claves clínicas para el diagnóstico. https://t.co/ma0OLbm1aR https://t.co/WddZBzI…
RT @jsenior64: Cardiomiopatía amiloide por transtiretina. Claves clínicas para el diagnóstico. https://t.co/ma0OLbm1aR https://t.co/WddZBzI…
RT @jsenior64: Cardiomiopatía amiloide por transtiretina. Claves clínicas para el diagnóstico. https://t.co/ma0OLbm1aR https://t.co/WddZBzI…
RT @jsenior64: Cardiomiopatía amiloide por transtiretina. Claves clínicas para el diagnóstico. https://t.co/ma0OLbm1aR https://t.co/WddZBzI…
RT @jsenior64: Cardiomiopatía amiloide por transtiretina. Claves clínicas para el diagnóstico. https://t.co/ma0OLbm1aR https://t.co/WddZBzI…
RT @jsenior64: Cardiomiopatía amiloide por transtiretina. Claves clínicas para el diagnóstico. https://t.co/ma0OLbm1aR https://t.co/WddZBzI…
Cardiomiopatía amiloide por transtiretina. Claves clínicas para el diagnóstico. https://t.co/ma0OLbm1aR https://t.co/WddZBzIEzu
RT @gonzaeperez: AMILOIDOSIS CARDÍACA Diagnóstico y manejo - Statement @American_Heart -Mejor evolución con Dx temprano. -Foco en dx por…
RT @CircAHA: AHA Scientific Statement: Cardiac Amyloidosis: Evolving Diagnosis and Management https://t.co/fLrPQPVJeF @AHAScience #AHAJourn…
https://t.co/bIrMMJliE5
RT @CircAHA: AHA Scientific Statement: Cardiac Amyloidosis: Evolving Diagnosis and Management https://t.co/fLrPQPVJeF @AHAScience #AHAJourn…
RT @CircAHA: AHA Scientific Statement: Cardiac Amyloidosis: Evolving Diagnosis and Management https://t.co/fLrPQPVJeF @AHAScience #AHAJourn…
RT @CircAHA: AHA Scientific Statement: Cardiac Amyloidosis: Evolving Diagnosis and Management https://t.co/fLrPQPVJeF @AHAScience #AHAJourn…
RT @CircAHA: AHA Scientific Statement: Cardiac Amyloidosis: Evolving Diagnosis and Management https://t.co/fLrPQPVJeF @AHAScience #AHAJourn…
RT @CircAHA: AHA Scientific Statement: Cardiac Amyloidosis: Evolving Diagnosis and Management https://t.co/fLrPQPVJeF @AHAScience #AHAJourn…
Deborah is the only Center in central Jersey with expertise in this sophisticated imaging capability to diagnose TTR type cardiac amyloidosis. To read the full article: https://t.co/0JtgAagw4a
So thorough, so well written! @MKIttlesonMD. https://t.co/qbYA9hYJ8Q #FOAMed #Meded #MedTwitter #internalmedicine #cardiotwitter #mededbot #medschool #cardiology https://t.co/OGGYAMMT4c
RT @CircAHA: AHA Scientific Statement: Cardiac Amyloidosis: Evolving Diagnosis and Management https://t.co/fLrPQPVJeF @AHAScience #AHAJourn…
RT @CircAHA: AHA Scientific Statement: Cardiac Amyloidosis: Evolving Diagnosis and Management https://t.co/fLrPQPVJeF @AHAScience #AHAJourn…
RT @CircAHA: AHA Scientific Statement: Cardiac Amyloidosis: Evolving Diagnosis and Management https://t.co/fLrPQPVJeF @AHAScience #AHAJourn…
RT @CircAHA: AHA Scientific Statement: Cardiac Amyloidosis: Evolving Diagnosis and Management https://t.co/fLrPQPVJeF @AHAScience #AHAJourn…
RT @CircAHA: AHA Scientific Statement: Cardiac Amyloidosis: Evolving Diagnosis and Management https://t.co/fLrPQPVJeF @AHAScience #AHAJourn…
RT @CircAHA: AHA Scientific Statement: Cardiac Amyloidosis: Evolving Diagnosis and Management https://t.co/fLrPQPVJeF @AHAScience #AHAJourn…
AHA Scientific Statement: Cardiac Amyloidosis: Evolving Diagnosis and Management https://t.co/fLrPQPVJeF @AHAScience #AHAJournals
Cardiac Amyloidosis Alert ⚠️⚠️⚠️: Evolving Diagnosis and Management: A Scientific Statement From the AHA @AHA_Research @AHAScience @CircAHA @AmyloidosisSupp @amyloid_papers @Amyloidosisfdn Check this out ⬇️⬇️⬇️❤️
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association. https://t.co/Usw4wQFpjm
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association | Circulation https://t.co/Qms96GsFiA https://t.co/BauruzGBHq
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
Imagen de esta tarde, "cherry on top"; amiloidosis cardiaca TTR con IC (FEVI 27%). ¡Cuánto por investigar! Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association | Circulation https://t.co/VZyNy2JlQA https://t.co/Q0ZiFu7d2X
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
RT @ValleAlfonso: Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From @AHAScience @CircAHA
doi:10.1161/CIR.0000000000000792. With Preserved, Borderline, and Reduced Ejection 19. Gilotra N, Okada D, Sharma A, Chrispin J. Manage- Fraction: 5-Year ...
Dynamics, Adona Medical, Millennia Biopharma, doi:10.1161/CIR.0000000000001039 a consensus report from the Bleeding Academic Oxitope, Cardiac Success, and ...
https://doi.org/10.1097/MED.0000000000000792 - Resumen: Actualiza las ... https://doi.org/10.1161/01.CIR.101.3.336 - Diferencias entre hipertrofia ...
Circulation. 2020;doi:10.1161/CIR.0000000000000792. Koyama J, et al. J Echocardiogr. 2019;doi:10.1007/s12574-019- ...
doi: 10.1161/CIR.0000000000000792. P, et al. Clinical Recommendations for Cardiovascular Magnetic Resonance Mapping of T1, T2, T2* and Extracellular Volume ...
2021;372:n71. doi: 10.1161/CIR.0000000000000792 doi: 10.1136/bmj.n71 4. Damy T, Garcia-Pavia P, Hanna M, et al. Efficacy and 15. Baethge C ...
doi:10.1161/CIR.0000000000000792 · 3. Mueller PS, Edwards WD, Gertz MA. Symptomatic ischemic heart disease resulting from obstructive ...
doi: 10.1161/CIR.0000000000000792. Errata in: Circulation. 2021;144(1):e10 and Circulation. 2021;144(1):e11. Pour-Ghaz I, Bath A, Kayali S ...
... 10.1161/cir.0000000000000792 - Palladini, G., Milani, P., & Merlini, G. (2020). Management of AL amyloidosis in 2020. Blood, 136(23), 2620 ...
doi:10.1161/CIR.0000000000000792 Published corrections appear in Circulation. 2021;144(1):e10 and Circulation. 2021;144(1):e11. 20. Akcea ...
... 10.1161/CIR.0000000000000792. Copy Link. Share. Share via 4d8r3LNRNR6geMGb53tnuc-facebook · Share via 4d8r3LNRNR6geMGb53tnuc-pinterest · Share ...
... 10.1161/CIR.0000000000000792. Copy Link. Share. Share via 3F6GM0vgcEnd0Lx4GPnPmB-facebook · Share via 3F6GM0vgcEnd0Lx4GPnPmB-pinterest · Share ...
... 10.1161/CIR.0000000000000792 Що змінилося: Дослідження показали, що ATTR-CM є недодіагностованою хворобою серед пацієнтів із СН (до 10 ...
1161/CIR.0000000000000792. Lexi-Drugs Online. Hudson, OH: Lexi-Comp ... 2020;doi:10.1161/CIRCULATIONAHA.119.044976. Rosenblum H, et al ...
2020;doi:10.1161/CIR.0000000000000792. Published by: cardiology today logo. Sources/Disclosures. Source: Ruberg FL. Amyloid-Best Practices ...
... //www.ahajournals.org/doi/10.1161/CIR. 0000000000000792. Jennifer Marie and 49 others ·
AV
VD
JM
DE
RE
C
C
BB
NM
PM
NM
PC
RG
KB
SM
AM
AR
RM
G
AS
PM
RF
CO
AP
دس
SG
DW
AF
SZ
KJ
BF
CB
JD
FV
PB
S
JD
MP
DR
GV
L
S
PH
EP
DC
EM
SM
TG
GM
AC
TD
GG
SM
MR
S
ER
RS
AB
D
DA
DE
DP
JL
JS
LG
SC
SH
EN
JC
LZ
TB
A
M
RP
J
PF
O
DS
MJ
Č
M
ER
R
IM
JA
MG
OS
I
C
EM
H
JS
RM
VZ
MM
抗
C日
J
DC
AM
JV
CP
AC
MA
H
SS
CD
RP
AP
NS
GG
HZ
DC
DN
HR
H
DR
SA
LL
F
UK
P
DS
AS
JM
D
S
NM
JF
DY
D
S
ES
AC
FF
R
VA
CS
C